Cargando…
Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers
CONTEXT: Classical antiretroviral agents may acutely impact on metabolic, mitochondrial, renal and hepatic function in HIV-infected and uninfected persons. Fusion and integrase inhibitors are supposed to be safer, but have been scarcely investigated. To avoid any interference with HIV or other antir...
Autores principales: | Barroso, Sergio, Morén, Constanza, González-Segura, Àlex, Riba, Neus, Arnaiz, Joan A., Manriquez, Marcela, Santana, Gemina, Blanco, José L., Larousse, María, Loncà, Montse, de Lazzari, Elisa, Llopis, Jaume, Mallolas, Josep, Miró, Oscar, Carné, Xavier, Gatell, Jose M., Garrabou, Glòria, Martínez, Esteban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532851/ https://www.ncbi.nlm.nih.gov/pubmed/31120908 http://dx.doi.org/10.1371/journal.pone.0216712 |
Ejemplares similares
-
Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial
por: de Castro, Nathalie, et al.
Publicado: (2016) -
Enfuvirtide antiretroviral therapy in HIV-1 infection
por: Kitchen, Christina MR, et al.
Publicado: (2008) -
Enfuvirtide in therapy at patients with HIV-infection and tuberculosis
por: Kravchenko, AV, et al.
Publicado: (2010) -
Enfuvirtide biosynthesis in thermostable chaperone-based fusion
por: Zenin, Vladimir, et al.
Publicado: (2022) -
Mitochondrial toxicity and caspase activation in HIV pregnant women
por: Hernandez, Sandra, et al.
Publicado: (2016)